443 related articles for article (PubMed ID: 23658436)
1. Intracoronary infusion of allogeneic mesenchymal precursor cells directly after experimental acute myocardial infarction reduces infarct size, abrogates adverse remodeling, and improves cardiac function.
Houtgraaf JH; de Jong R; Kazemi K; de Groot D; van der Spoel TI; Arslan F; Hoefer I; Pasterkamp G; Itescu S; Zijlstra F; Geleijnse ML; Serruys PW; Duckers HJ
Circ Res; 2013 Jul; 113(2):153-66. PubMed ID: 23658436
[TBL] [Abstract][Full Text] [Related]
2. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
[TBL] [Abstract][Full Text] [Related]
3. Intracoronary infusion of encapsulated glucagon-like peptide-1-eluting mesenchymal stem cells preserves left ventricular function in a porcine model of acute myocardial infarction.
de Jong R; van Hout GP; Houtgraaf JH; Kazemi K; Wallrapp C; Lewis A; Pasterkamp G; Hoefer IE; Duckers HJ
Circ Cardiovasc Interv; 2014 Oct; 7(5):673-83. PubMed ID: 25294400
[TBL] [Abstract][Full Text] [Related]
4. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging.
Britten MB; Abolmaali ND; Assmus B; Lehmann R; Honold J; Schmitt J; Vogl TJ; Martin H; Schächinger V; Dimmeler S; Zeiher AM
Circulation; 2003 Nov; 108(18):2212-8. PubMed ID: 14557356
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of improvement of left ventricle remodeling by trans-planting two kinds of autologous bone marrow stem cells in pigs.
Li SR; Qi XY; Hu FL; Zhang JQ; Wang TH; Dang Y; Meng CL; Liu HL; Li YX; Wu D; Dong J; Xun LY; Gao LH; Jin FC
Chin Med J (Engl); 2008 Dec; 121(23):2403-9. PubMed ID: 19102957
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial.
Kang HJ; Lee HY; Na SH; Chang SA; Park KW; Kim HK; Kim SY; Chang HJ; Lee W; Kang WJ; Koo BK; Kim YJ; Lee DS; Sohn DW; Han KS; Oh BH; Park YB; Kim HS
Circulation; 2006 Jul; 114(1 Suppl):I145-51. PubMed ID: 16820564
[TBL] [Abstract][Full Text] [Related]
7. Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction.
Halkos ME; Zhao ZQ; Kerendi F; Wang NP; Jiang R; Schmarkey LS; Martin BJ; Quyyumi AA; Few WL; Kin H; Guyton RA; Vinten-Johansen J
Basic Res Cardiol; 2008 Nov; 103(6):525-36. PubMed ID: 18704259
[TBL] [Abstract][Full Text] [Related]
8. A novel approach to transplanting bone marrow stem cells to repair human myocardial infarction: delivery via a noninfarct-relative artery.
Yang Z; Zhang F; Ma W; Chen B; Zhou F; Xu Z; Zhang Y; Zhang D; Zhu T; Wang L; Wang H; Ding Z; Zhang Y
Cardiovasc Ther; 2010 Dec; 28(6):380-5. PubMed ID: 20337639
[TBL] [Abstract][Full Text] [Related]
9. Catheter-based endomyocardial delivery of mesenchymal precursor cells using 3D echo guidance improves cardiac function in a chronic myocardial injury ovine model.
Cheng Y; Yi G; Conditt GB; Sheehy A; Kolodgie FD; Tellez A; Polyakov I; Gu A; Aboodi MS; Wallace-Bradley D; Schuster M; Martens T; Itescu S; Kaluza GL; Basu S; Virmani R; Granada JF; Sherman W
Cell Transplant; 2013; 22(12):2299-309. PubMed ID: 23107489
[TBL] [Abstract][Full Text] [Related]
10. Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling.
Zeng L; Hu Q; Wang X; Mansoor A; Lee J; Feygin J; Zhang G; Suntharalingam P; Boozer S; Mhashilkar A; Panetta CJ; Swingen C; Deans R; From AH; Bache RJ; Verfaillie CM; Zhang J
Circulation; 2007 Apr; 115(14):1866-75. PubMed ID: 17389266
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous adventitial delivery of allogeneic bone marrow-derived stem cells via infarct-related artery improves long-term ventricular function in acute myocardial infarction.
Medicetty S; Wiktor D; Lehman N; Raber A; Popovic ZB; Deans R; Ting AE; Penn MS
Cell Transplant; 2012; 21(6):1109-20. PubMed ID: 22004910
[TBL] [Abstract][Full Text] [Related]
12. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial.
Schächinger V; Assmus B; Britten MB; Honold J; Lehmann R; Teupe C; Abolmaali ND; Vogl TJ; Hofmann WK; Martin H; Dimmeler S; Zeiher AM
J Am Coll Cardiol; 2004 Oct; 44(8):1690-9. PubMed ID: 15489105
[TBL] [Abstract][Full Text] [Related]
13. Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the Doppler Substudy of the Reinfusion of Enriched Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (REPAIR-AMI) trial.
Erbs S; Linke A; Schächinger V; Assmus B; Thiele H; Diederich KW; Hoffmann C; Dimmeler S; Tonn T; Hambrecht R; Zeiher AM; Schuler G
Circulation; 2007 Jul; 116(4):366-74. PubMed ID: 17620510
[TBL] [Abstract][Full Text] [Related]
14. Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function.
Yao K; Huang R; Qian J; Cui J; Ge L; Li Y; Zhang F; Shi H; Huang D; Zhang S; Sun A; Zou Y; Ge J
Heart; 2008 Sep; 94(9):1147-53. PubMed ID: 18381377
[TBL] [Abstract][Full Text] [Related]
15. Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction.
Perin EC; Silva GV; Assad JA; Vela D; Buja LM; Sousa AL; Litovsky S; Lin J; Vaughn WK; Coulter S; Fernandes MR; Willerson JT
J Mol Cell Cardiol; 2008 Mar; 44(3):486-95. PubMed ID: 18061611
[TBL] [Abstract][Full Text] [Related]
16. Nonocclusive multivessel intracoronary infusion of allogeneic cardiosphere-derived cells early after reperfusion prevents remote zone myocyte loss and improves global left ventricular function in swine with myocardial infarction.
Suzuki G; Weil BR; Young RF; Fallavollita JA; Canty JM
Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H345-H356. PubMed ID: 31125261
[TBL] [Abstract][Full Text] [Related]
17. Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.
Hirsch A; Nijveldt R; van der Vleuten PA; Biemond BJ; Doevendans PA; van Rossum AC; Tijssen JG; Zijlstra F; Piek JJ;
Am Heart J; 2006 Sep; 152(3):434-41. PubMed ID: 16923409
[TBL] [Abstract][Full Text] [Related]
18. Transcoronary transplantation of progenitor cells after myocardial infarction.
Assmus B; Honold J; Schächinger V; Britten MB; Fischer-Rasokat U; Lehmann R; Teupe C; Pistorius K; Martin H; Abolmaali ND; Tonn T; Dimmeler S; Zeiher AM
N Engl J Med; 2006 Sep; 355(12):1222-32. PubMed ID: 16990385
[TBL] [Abstract][Full Text] [Related]
19. [Effect of persistent microvascular obstruction on post-infarction ventricular remodeling following intracoronary bone-marrow cell transplantation: a contrast-enhanced cardiac magnetic resonance study].
Villa A; Tejedor-Viñuela P; Sánchez PL; Tapia C; Arnold R; Gómez-Salvador I; García-Frade LJ; Sánchez A; Fernández-Avilés F; San Román JA
Rev Esp Cardiol; 2008 Jun; 61(6):602-10. PubMed ID: 18570781
[TBL] [Abstract][Full Text] [Related]
20. Cell therapy with autologous bone marrow mononuclear stem cells is associated with superior cardiac recovery compared with use of nonmodified mesenchymal stem cells in a canine model of chronic myocardial infarction.
Mathieu M; Bartunek J; El Oumeiri B; Touihri K; Hadad I; Thoma P; Metens T; da Costa AM; Mahmoudabady M; Egrise D; Blocklet D; Mazouz N; Naeije R; Heyndrickx G; McEntee K
J Thorac Cardiovasc Surg; 2009 Sep; 138(3):646-53. PubMed ID: 19698851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
